This inventor holds 1 USPTO granted patent. Top assignee: Purzer Pharmaceutical Co., Ltd.. Active years: 2006.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2006
Title: Shigi Peng: Innovator in Cyclic Pentapeptides
Introduction
Shigi Peng is a notable inventor based in Beijing, China. He has made significant contributions to the field of cyclic peptides, particularly with his innovative patent that showcases the potential therapeutic effects of these compounds.
Latest Patents
Shigi Peng holds a patent for "Cyclic pentapeptides and their preparation." This invention relates to cyclic peptides with the formula (I) (SEQ ID NO: 1), cyclo(Xaa-Arg-Pro-Ala-Lys), where Xaa can be Ala, Gly, Glu, Gln, Asp, Asn, Arg, or Lys. The cyclic peptides developed by Peng exhibit thrombolytic effects, making them valuable in medical applications. This patent highlights his expertise in peptide chemistry and its implications for health.
Career Highlights
Shigi Peng is associated with Purzer Pharmaceutical Co., Ltd., where he continues to advance his research and development efforts. His work in the pharmaceutical industry emphasizes the importance of innovation in creating effective therapeutic solutions.
Collaborations
Shigi collaborates with talented individuals such as Lin Na and Chao Wang, contributing to a dynamic research environment that fosters creativity and scientific advancement.
Conclusion
Shigi Peng's contributions to the field of cyclic pentapeptides demonstrate his commitment to innovation and the potential impact of his work on medical science. His patent reflects a significant step forward in the development of therapeutic agents.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile